(Q38816052)

6 September 2017

TGF-β: the master regulator of fibrosis (English)

1 reference

6 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108839%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Hui Y Lan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108839%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

author name string

David J Nikolic-Paterson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108839%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

language of work or name

English

0 references

publication date

25 April 2016

1 reference

Nature Reviews Nephrology

6 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108839%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108839%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108839%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

325-338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27108839%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneph.2016.48

4 June 2020

exact match

0 references

cites work

Chronic kidney disease progression.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta signaling in renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Overview of the cellular and molecular basis of kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Increased renal production of transforming growth factor-beta1 in patients with type II diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

IN-1130, a novel transforming growth factor-beta type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Role of the TGF-β/BMP-7/Smad pathways in renal diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Non-Smad pathways in TGF-beta signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta isoforms in renal fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Post-translational regulation of TGF-β receptor and Smad signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Latent TGF-β-binding proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Making sense of latent TGFbeta activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mice overexpressing latent TGF-beta1 are protected against renal fibrosis in obstructive kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Latent TGF-beta1 protects against crescentic glomerulonephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor-beta regulates production of proteoglycans by mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Insight on the pathogenesis of diabetic nephropathy from the study of podocyte and mesangial cell biology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta receptor deletion in the renal collecting system exacerbates fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta receptor function in the endothelium.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Upregulation of mitochondrial Nox4 mediates TGF-β-induced apoptosis in cultured mouse podocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Origin of myofibroblasts and cellular events triggering fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Stimulation of Type I Collagen Transcription in Human Skin Fibroblasts by TGF-β: Involvement of Smad 3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Direct binding of Smad3 and Smad4 to critical TGF beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Smad3 deficiency attenuates renal fibrosis, inflammation,and apoptosis after unilateral ureteral obstruction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Activation of the TGF-beta/Smad signaling pathway in focal segmental glomerulosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mechanism of chronic aristolochic acid nephropathy: role of Smad3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Role of Smad4 on TGF-beta-induced extracellular matrix stimulation in mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Smad7: not only a regulator, but also a cross-talk mediator of TGF-β signalling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mitogen activated protein kinases in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Glomerular and tubular induction of the transcription factor c-Jun in human renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

p38 Mitogen-activated protein kinase activation and cell localization in human glomerulonephritis: correlation with renal injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The role of p38alpha mitogen-activated protein kinase activation in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The mitogen-activated protein kinase p38α regulates tubular damage in murine anti-glomerular basement membrane nephritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mechanical stretch-induced fibronectin and transforming growth factor-beta1 production in human mesangial cells is p38 mitogen-activated protein kinase-dependent

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

ASK1/p38 signaling in renal tubular epithelial cells promotes renal fibrosis in the mouse obstructed kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

S100B is required for high glucose-induced pro-fibrotic gene expression and hypertrophy in mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-β1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor-β signalling: role and consequences of Smad linker region phosphorylation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta activates Erk MAP kinase signalling through direct phosphorylation of ShcA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Stimulation of pro-alpha(1)(I) collagen by TGF-beta(1) in mesangial cells: role of the p38 MAPK pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Lefty antagonises TGF-beta1 induced epithelial-mesenchymal transition in tubular epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

AEG-1 participates in TGF-beta1-induced EMT through p38 MAPK activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Wnt/β-catenin signaling and kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Targeted inhibition of β-catenin/CBP signaling ameliorates renal interstitial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Wnt/beta-catenin signaling promotes renal interstitial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Beta-catenin and transforming growth factor beta have distinct roles regulating fibroblast cell motility and the induction of collagen lattice contraction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta modulates beta-Catenin stability and signaling in mesenchymal proliferations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Genetic or pharmacologic blockade of EGFR inhibits renal fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

EGFR signaling promotes TGFβ-dependent renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

EGF Receptor Inhibition Alleviates Hyperuricemic Nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Novel Epidermal Growth Factor Receptor Inhibitor Attenuates Angiotensin II-Induced Kidney Fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

EGFR signaling in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mammalian target of rapamycin and the kidney. I. The signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Mammalian target of rapamycin and the kidney. II. Pathophysiology and therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The role of the mammalian target of rapamycin (mTOR) in renal disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor β integrates Smad 3 to mechanistic target of rapamycin complexes to arrest deptor abundance for glomerular mesangial cell hypertrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Rictor/mTORC2 signaling mediates TGFβ1-induced fibroblast activation and kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Links between tumor suppressors: p53 is required for TGF-beta gene responses by cooperating with Smads.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Redox control of p53 in the transcriptional regulation of TGF-β1 target genes through SMAD cooperativity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor-β-induced cross talk between p53 and a microRNA in the pathogenesis of diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Renal Bone Morphogenetic Protein-7 Protects against Diabetic Nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

BMP-7 and proximal tubule epithelial cells: activation of multiple signaling pathways reveals a novel anti-fibrotic mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Differential regulation of E-cadherin and alpha-smooth muscle actin by BMP 7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

ALK1-Smad1/5 signaling pathway in fibrosis development: friend or foe?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Endoglin haploinsufficiency reduces radiation-induced fibrosis and telangiectasia formation in mouse kidneys

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The role of endoglin in kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Endoglin upregulation during experimental renal interstitial fibrosis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Endoglin expression in human and rat mesangial cells and its upregulation by TGF-beta1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Expression of endoglin in human mesangial cells: modulation of extracellular matrix synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

AMP-activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Notch in the kidney: development and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Notch signaling is necessary for epithelial growth arrest by TGF-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The Notch pathway in podocytes plays a role in the development of glomerular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The Whereabouts of microRNA Actions: Cytoplasm and Beyond.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Identification of a microRNA signature in renal fibrosis: role of miR-21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

miR-21 promotes renal fibrosis in diabetic nephropathy by targeting PTEN and SMAD7.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Smad3-mediated upregulation of miR-21 promotes renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNAs in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA-target pairs in human renal epithelial cells treated with transforming growth factor beta 1: a novel role of miR-382.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The microRNA miR-433 promotes renal fibrosis by amplifying the TGF-β/Smad3-Azin1 pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Repression of let-7 by transforming growth factor-β1-induced Lin28 upregulates collagen expression in glomerular mesangial cells under diabetic conditions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The microRNA-15 family inhibits the TGFβ-pathway in the heart

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Suppression of microRNA-29 expression by TGF-β1 promotes collagen expression and renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA-29b inhibits peritoneal fibrosis in a mouse model of peritoneal dialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

A microRNA-30e/mitochondrial uncoupling protein 2 axis mediates TGF-β1-induced tubular epithelial cell extracellular matrix production and kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA miR145 regulates TGFBR2 expression and matrix synthesis in vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

miR-145 regulates myofibroblast differentiation and lung fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

miR-192 mediates TGF-beta/Smad3-driven renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

miR-200b precursor can ameliorate renal tubulointerstitial fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Structure and function of long noncoding RNAs in epigenetic regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Identification of novel long noncoding RNAs associated with TGF-β/Smad3-mediated renal inflammation and fibrosis by RNA sequencing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Evidence for the involvement of epigenetics in the progression of renal fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Epigenetic alterations in acute kidney injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The role of promoter hypermethylation in fibroblast activation and fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Methylation determines fibroblast activation and fibrogenesis in the kidney

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Tet3-mediated hydroxymethylation of epigenetically silenced genes contributes to bone morphogenic protein 7-induced reversal of kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Epigenetic repression of Krüppel-like factor 4 through Dnmt1 contributes to EMT in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Repression of Smad7 mediated by DNMT1 determines hepatic stellate cell activation and liver fibrosis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Charting histone modifications and the functional organization of mammalian genomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Diabetic nephropathy--emerging epigenetic mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Epigenetic histone methylation modulates fibrotic gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Histone modifications in transcriptional regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Involvement of p300/CBP and epigenetic histone acetylation in TGF-β1-mediated gene transcription in mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Smad3 is acetylated by p300/CBP to regulate its transactivation activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Blocking the class I histone deacetylase ameliorates renal fibrosis and inhibits renal fibroblast activation via modulating TGF-beta and EGFR signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Epigenetic cancer therapy: rationales, targets and drugs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-β/Smad3 pathway.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Diverse origins of the myofibroblast—implications for kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Host responses in tissue repair and fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Identification and characterization of a fibroblast marker: FSP1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Molecular mechanisms of epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The origin of interstitial myofibroblasts in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Origin and function of myofibroblasts in kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Regulation of endothelial cell plasticity by TGF-β

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Fibrocytes develop outside the kidney but contribute to renal fibrosis in a mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Fibrocytes: a new insight into kidney fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Macrophages promote renal fibrosis through direct and indirect mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Macrophage-specific deletion of transforming growth factor-β1 does not prevent renal fibrosis after severe ischemia-reperfusion or obstructive injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

TGF-beta signal transduction and mesangial cell fibrogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

RhoA/Rho kinase mediates TGF-β1-induced kidney myofibroblast activation through Poldip2/Nox4-derived reactive oxygen species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Fibroblast activation and myofibroblast generation in obstructive nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Transforming growth factor β-1 stimulates profibrotic epithelial signaling to activate pericyte-myofibroblast transition in obstructive kidney fibrosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Hepatocyte growth factor in kidney fibrosis: therapeutic potential and mechanisms of action

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Pirfenidone for diabetic nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Pirfenidone Slows Renal Function Decline in Patients with Focal Segmental Glomerulosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Pirfenidone treatment decreases transforming growth factor-beta1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

GQ5 Hinders Renal Fibrosis in Obstructive Nephropathy by Selectively Inhibiting TGF-β-Induced Smad3 Phosphorylation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Apoptosis in podocytes induced by TGF-beta and Smad7

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2016.48

Role of bone morphogenetic protein-7 in renal fibrosis

31 March 2020

1 reference

12 December 2020

p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration.

1 reference

12 December 2020

Differentiation of circulating monocytes into fibroblast-like cells.

1 reference

12 December 2020

Effect of transforming growth factor-beta 1 on plasminogen activators and plasminogen activator inhibitor-1 in renal glomerular cells

1 reference

12 December 2020

Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblasts

1 reference

12 December 2020

Epithelial cell alpha3beta1 integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis

1 reference

12 December 2020

FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype

1 reference

12 December 2020

Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney

1 reference

12 December 2020

Transforming growth factor-beta protein and mRNA in glomeruli in normal and diseased human kidneys

1 reference

12 December 2020

TGF-β/Smad signaling in renal fibrosis

1 reference

12 December 2020

MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways

1 reference

12 December 2020

Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin.

1 reference

12 December 2020

Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy

1 reference

12 December 2020

TGF-beta stimulates rat mesangial cell proliferation in culture: role of PDGF beta-receptor expression

1 reference

12 December 2020

Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice.

1 reference

12 December 2020

Endoglin, a transforming growth factor-beta-binding protein, is upregulated in chronic progressive renal disease

1 reference

12 December 2020

Transdifferentiation of macrophages into fibroblasts as a result of Schistosoma mansoni infection

1 reference

12 December 2020